Diagnostic value of contrast-enhanced ultrasound combined with other imaging techniques in differentiating benign and malignant thyroid nodules: a network meta-analysis
Frontiers in Endocrinology · 2026
DOI: 10.3389/fendo.2026.1887134 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift Frontiers in Endocrinology, 2026. Verfasst von Qingying Xie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Thyroid Nodule, Contrast Media, Thyroid Neoplasms. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This network meta-analysis (NMA) intends to fully assess the value of contrast-enhanced ultrasound (CEUS) combined with other imaging techniques in the diagnosis of thyroid nodules (TNs), and provide clinical guidance.
Methods
We systematically searched PubMed, Web of Science, Embase, and Cochrane up to October 15, 2025, and assessed study quality by the QUADAS-2 tool. The combination of CEUS and CEUS with other techniques was assessed for accuracy by R4.5.1 and ANOVA-based NMA.
Results
Twenty-six original studies were included, encompassing 5022 TNs from 4484 patients. CEUS-ultrasound elastography (UE) demonstrated favorable diagnostic performance in differentiating benign and malignant TNs (superiority index [SI]: 3.47, 95%CI 0.2–7). The pooled sensitivity (SE) and specificity (SP) of CEUS-UE were 0.92 (95%CI 0.88–0.95, SUCRA 80.0%) and 0.83 (95%CI 0.75–0.89, SUCRA 60.7%), respectively. CEUS-artificial intelligence (AI) was generally effective in identifying high-risk TNs (SI: 3.81, 95%CI 0.33–9), with pooled SE and SP of 0.95 (95%CI 0.91–0.98, SUCRA 90.0%) and 0.81 (95%CI 0.68–0.91, SUCRA 49.6%), respectively. CEUS-conventional ultrasound (US) showed favorable diagnostic performance in identifying non-risk-stratified TNs (SI: 5.29, 95%CI 0.33–9), with pooled SE and SP of 0.89 (95% CI 0.74–0.97, SUCRA 61.4%) and 0.88 (95%CI 0.69–0.97, SUCRA 76.9%), respectively.
Conclusion
CEUS-UE demonstrates favorable overall diagnostic performance in differentiating benign and malignant TNs. CEUS-AI may offer additional value in identifying high-risk TNs with multiple suspicious features. CEUS-US is effective in identifying non-risk-stratified TNs. However, these subgroup findings require further validation in larger, diverse external cohorts. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/myprospero , identifier CRD420251169562.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
- Endocrine Department I, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
Zitieren
APA
Xie, Q., Yang, Z., Sun, Y., Zhao, N., Hou, R., Di, Z., & Ma, J. (2026). Diagnostic value of contrast-enhanced ultrasound combined with other imaging techniques in differentiating benign and malignant thyroid nodules: a network meta-analysis. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1887134
Vancouver
Xie Q, Yang Z, Sun Y, Zhao N, Hou R, Di Z, et al. Diagnostic value of contrast-enhanced ultrasound combined with other imaging techniques in differentiating benign and malignant thyroid nodules: a network meta-analysis. Frontiers in Endocrinology. 2026. doi:10.3389/fendo.2026.1887134
BibTeX
@article{Xie2026,
author = {Xie, Qingying and Yang, Zhuoshi and Sun, Yue and Zhao, Na and Hou, Ruirui and Di, Zhiyue and Ma, Jian},
title = {Diagnostic value of contrast-enhanced ultrasound combined with other imaging techniques in differentiating benign and malignant thyroid nodules: a network meta-analysis},
journal = {Frontiers in Endocrinology},
year = {2026},
doi = {10.3389/fendo.2026.1887134}
}
EUVIMED